Nilesh Wagh

Title: Nilesh Wagh: Innovator in Cancer Treatment

Introduction

Nilesh Wagh is a prominent inventor based in Houston, TX (US), known for his significant contributions to cancer treatment. He has developed innovative methods targeting cancer cells that overexpress somatostatin receptors. His work is crucial in advancing therapeutic options for patients battling cancer.

Latest Patents

Nilesh Wagh holds a patent for a composition and method aimed at treating cancer cells overexpressing somatostatin receptors. The patent, titled "Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes," describes a cancer-targeting composition that includes a radioisotope, a chelator, and a targeting moiety. The chelator features a nitrogen ring structure, which may include derivatives such as tetraazacyclododecane, triazacyclononane, and tetraazabicyclo [6.6.2] hexadecane. The targeting moiety consists of a somatostatin receptor targeting peptide, specifically an octreotide derivative, which is chelated to the radioisotope by the chelator, allowing for targeted elimination of cancer cells.

Career Highlights

Throughout his career, Nilesh Wagh has worked with notable companies in the medical field, including Radiomedix Inc. and Orano Med. His experience in these organizations has contributed to his expertise in developing innovative cancer treatment solutions.

Collaborations

Nilesh has collaborated with esteemed professionals in his field, including Izabela Tworowska and Ebrahim S Delpassand. These collaborations have further enhanced his research and development efforts in cancer treatment.

Conclusion

Nilesh Wagh's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His patent and collaborations highlight his commitment to advancing healthcare solutions for cancer patients.